n-palmitoylglycine has been researched along with oleylamide in 1 studies
| Studies (n-palmitoylglycine) | Trials (n-palmitoylglycine) | Recent Studies (post-2010) (n-palmitoylglycine) | Studies (oleylamide) | Trials (oleylamide) | Recent Studies (post-2010) (oleylamide) |
|---|---|---|---|---|---|
| 18 | 0 | 6 | 197 | 0 | 63 |
| Protein | Taxonomy | n-palmitoylglycine (IC50) | oleylamide (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burstein, S; Salmonsen, R | 1 |
1 other study(ies) available for n-palmitoylglycine and oleylamide
| Article | Year |
|---|---|
Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation.
Topics: Animals; Antineoplastic Agents; Cannabinoid Receptor Modulators; Cell Proliferation; Dopamine; Endocannabinoids; Fatty Acids, Unsaturated; Growth Inhibitors; HeLa Cells; Humans; Mice; Rats; Time Factors; Tumor Cells, Cultured; Tyrosine | 2008 |